Citation Impact
Citing Papers
Randomized Controlled Trial of Annual Zoledronic Acid to Prevent Gonadotropin-Releasing Hormone Agonist–Induced Bone Loss in Men With Prostate Cancer
2007
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2008
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
2004
Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults
2017
Prediction of lean body mass from multifrequency segmental impedance: influence of adiposity
2001
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
1993
Postmenopausal osteoporosis: patient choices and outcomes
1995
Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma
2000
Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency
2009
Dietary calcium intake and risk of cardiovascular disease, stroke, and fracture in a population with low calcium intake
2017
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
2010
Acromegaly
2006 Standout
Guide to Bone Health and Disease in Cystic Fibrosis
2005
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis
2011
An Osteoporosis Clinical Pathway for the Medical Management of Patients with Low-Trauma Fracture
2002
Osteoporosis
2019 Standout
A comparison of case-finding strategies in the UK for the management of hip fractures
2012
Kidney stones: pathophysiology and medical management
2006 Standout
A meta-analysis of previous fracture and subsequent fracture risk
2004
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases
2001
A reference standard for the description of osteoporosis
2007
Breast cancer
2016 Standout
Dynamics of fat cell turnover in humans
2008 StandoutNature
Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
2001
A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Sodium Clodronate for Metastatic Prostate Cancer (MRC PR05 Trial)
2003
Intranasal Salcatonin (Salmon Calcitonin)
1996
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Body mass index as a predictor of fracture risk: A meta-analysis
2005
Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide
2017
Weight management using a meal replacement strategy: meta and pooling analysis from six studies
2003
Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK
2008
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample
1997
Psychosocial and Behavioral Aspects of Bariatric Surgery
2005
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
2007
Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy
1995
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Comparison of the European and USA Practice Guidelines for Osteoporosis
2000
Alopecia and Hirsuties
1988
Vitamin D Deficiency
2007 Standout
Prediction of fracture from low bone mineral density measurements overestimates risk
2000
PATHOPHYSIOLOGY OF OSTEOPOROSIS
1998
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
2012
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Medical Care for the Final Years of Life
2009
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
2007
Osteoporosis: now and the future
2011 Standout
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis
2000
Bisphosphonates in prostate carcinoma
1997
FRAX® with and without Bone Mineral Density
2011
A family history of fracture and fracture risk: a meta-analysis
2004
Effect of calcitonin on bone mass and fracture rates
1991
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study
2004
Obesity
2005 Standout
Efficacy and Safety of Low-Carbohydrate Diets
2003
Four-month treatment with GLP-2 significantly increases hip BMD
2009
Systematic review of bisphosphonates for hypercalcaemia of malignancy
2004
The Pathogenesis and Treatment of Kidney Stones
1992
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden
2000
Requirements for DXA for the management of osteoporosis in Europe
2004
Graves' Ophthalmopathy
2010 Standout
Polycystic Ovary Syndrome
1995 Standout
Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies
2002
Hyperoxaluric calcium nephrolithiasis
2002
Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women
2010
Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review
2004
A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes
1997
Ten Year Probabilities of Osteoporotic Fractures According to BMD and Diagnostic Thresholds
2001
Bedside determination of fluid accumulation after cardiac surgery using segmental bioelectrical impedance
1998
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
BMD, clinical risk factors and their combination for hip fracture prevention
2009
Sarcopenia
2019 Standout
Assessment of fracture risk
2004
Persistent postsurgical pain: risk factors and prevention
2006 Standout
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Nutrition: its role in bone health
2008
Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids
2006
The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
2009
Activated Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins that Drive Human Orbital Fibroblast Differentiation to Adipocytes
2006
25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates
2010
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Severe vitamin D deficiency in Swiss hip fracture patients
2007
Intravenous ibandronate injections in postmenopausal women with osteoporosis: One‐year results from the dosing intravenous administration study
2006
Bone Loss and Turnover after Cardiac Transplantation1
1997
The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis
2009
The human adipose tissue is a source of multipotent stem cells
2004
Kidney stones
1998
Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria
2002 Standout
Do Markers of Bone Resorption Add to Bone Mineral Density and Ultrasonographic Heel Measurement for the Prediction of Hip Fracture in Elderly Women? The EPIDOS Prospective Study
1998
Calcium Absorption Varies within the Reference Range for Serum 25-Hydroxyvitamin D
2003
Osteoporosis after solid organ and bone marrow transplantation
2003
Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of Raloxifene Evaluation trial11Eli Lilly and Company (Indianapolis, IN) sponsored the Multiple Outcomes of Raloxifene Evaluation (MORE) trial.
2003
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Mechanisms of Bone Metastasis
2004 Standout
FRAX® assessment of osteoporotic fracture probability in Switzerland
2009
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone
2001
A meta-analysis of milk intake and fracture risk: low utility for case finding
2004
Prevalence of Vitamin D Insufficiency in an Adult Normal Population
1997 Standout
Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases
2008
Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia
2018
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Vitamin D Supplementation and Total Mortality<subtitle>A Meta-analysis of Randomized Controlled Trials</subtitle>
2007
Bisphosphonates
1991
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Bisphosphonates: A review of their pharmacokinetic properties
1996
Frailty in elderly people
2013 Standout
Role of Dual-Energy X-Ray Absorptiometry in the Diagnosis and Treatment of Osteoporosis
2006
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
2009
High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry
1999
Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study
2008
Prevention of falls and consequent injuries in elderly people
2005 Standout
Alcohol intake as a risk factor for fracture
2004
Neuropathic pain: aetiology, symptoms, mechanisms, and management
1999 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Gait Speed and Survival in Older Adults
2011 Standout
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
A systematic review of intervention thresholds based on FRAX
2016
Functional indices of vitamin D status and ramifications of vitamin D deficiency
2004
Bioelectrical impedance analysis?part I: review of principles and methods
2004 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001
Preventing the Development of Complex Regional Pain Syndrome after Surgery
2004
Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective
2008
Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study
2005
Vitamin D and Health: Perspectives From Mice and Man
2008
Is there Any Interest in Combining Treatments in Osteoporosis?
2005
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
2000 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
International Variations in Hip Fracture Probabilities: Implications for Risk Assessment
2002
Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction.
1986
Italian guidelines for the diagnosis and treatment of Paget’s disease of bone
2011
Pharmacological and surgical treatment of obesity.
2004
Does the Combination of Two BMD Measurements Improve Fracture Discrimination?
2003
Bisphosphonates in prostate carcinoma
1997
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Vitamin D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
2011
Hyperglycaemia, Diabetes and Myocardial Infarction
1987
An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women
2010
Smoking and fracture risk: a meta-analysis
2004
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
2014
Increased Prevalence of Radiological Spinal Deformities in Active Acromegaly: A Cross-Sectional Study in Postmenopausal Women
2005
Timing and quantification of bone loss in cardiac transplant recipients
1995
Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
2003
A Meta-Analysis of Prior Corticosteroid Use and Fracture Risk
2004
Segmental bioelectrical impedance analysis
2003
Correcting calcium nutritional deficiency prevents spine fractures in elderly women
1996
[A FRAX model for the assessment of fracture probability in Belgium].
2009
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Skeletal complications of malignancy
1997 Standout
The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland
2011
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Update in Vitamin D
2010
BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMA
1999
Efficient Total Synthesis of Novel Bioactive Microbial Metabolites
2008 StandoutNobel
Oral bisphosphonates
2000
Quantitative Ultrasound Techniques for the Assessment of Osteoporosis: Expert Agreement on Current Status
1997
Optimization of BMD Measurements to Identify High Risk Groups for Treatment—A Test Analysis
2004
11 Treatment of hirsutism and acne with cyproterone acetate
1986
Vitamin D Status Predicts Physical Performance and Its Decline in Older Persons
2007
Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline
2016
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Prevention of Stone Formation and Bone Loss In Absorptive Hypercalciuria by Combined Dietary and Pharmacological Interventions
2003
Works of P. Burckhardt being referenced
The peak bone mass concept
1989
The Effect of the Alkali Load of Mineral Water on Bone Metabolism: Interventional Studies ,
2008
Three Monthly Intravenous Injections of Ibandronate in the Treatment of Postmenopausal Osteoporosis
1997
The effect of treatment with calcitonin on vertebral fracture rate in osteoporosis
1993
Pharmacokinetics of Pamidronate in Patients With Bone Metastases
1992
Quantitative ultrasound of bone in institutionalized elderly women: A cross-sectional and longitudinal study
1996
Treatment of Tumor-Induced Osteolysis by APD
1989
Comparison of a rapid (2-h) versus a slow (24-h) infusion of alendronate in the treatment of hypercalcemia of malignancy
1992
Treatment of bone metastases from breast cancer and myeloma with pamidronate
1991
Serum 25-hydroxyvitamin D: distribution and determinants in the Swiss population
1992
Global vitamin D status and determinants of hypovitaminosis D
2009
Quality Controls for Two Heel Bone Ultrasounds Used in the Swiss Evaluation of the Methods of Measurement of Osteoporotic Fracture Risk Study
2002
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
1998
Molecular Determinants of Human Adipose Tissue: Differences between Visceral and Subcutaneous Compartments in Obese Women
2004
Importance of Albumin, 25(OH)-Vitamin D and IGFBP-3 as Risk Factors in Elderly Women and Men with Hip Fracture
1997
Guidelines for diagnosis and management of osteoporosis
1997
Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials
2007
A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone
1988
IOF position statement: vitamin D recommendations for older adults
2010
Energy and nutrient intake of Swiss women aged 75–87 years
2006
Effect of Supplementation with Vitamin D 3 and Calcium on Quantitative Ultrasound of Bone in Elderly Institutionalized Women: A Longitudinal Study
1999
The effect of rectal and nasal administration of salmon calcitonin in normal subjects
1987
Calcium and Vitamin D in Osteoporosis: Supplementation or Treatment?
2002
Ibandronate in oncology
1997
Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP.
1988
Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause
1994
Intravenous Pamidronate as Treatment for Osteoporosis after Heart Transplantation: A Prospective Study
2001
Prevention of recurrent hip fracture
2000
Reconstitution of telomerase activity combined with HPV-E7 expression allow human preadipocytes to preserve their differentiation capacity after immortalization
2003
Bone mineral content in cystic fibrosis patients: correlation with fat-free mass.
1996
Expression of Peroxisome Proliferator-Activated Receptor-γ1 and Peroxisome Proliferator-Activated Receptor-γ2 in Visceral and Subcutaneous Adipose Tissue of Obese Women
2003
Segmental body composition assessed by bioelectrical impedance analysis and DEXA in humans
1996
Prediction of Hip Fracture Risk by Quantitative Ultrasound in More Than 7000 Swiss Women ≥70 Years of Age: Comparison of Three Technologically Different Bone Ultrasound Devices in the SEMOF Study
2006
[Simple treatment of tumor-induced hypercalcemia: i.v. aminohydroxypropylidene biphosphonate].
1983
Fighting osteoporosis on two fronts
2006
Balanced hypocaloric diet versus protein-sparing modified fast in the treatment of obesity: a comparative study.
1982
[Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
1999
Adrenocortical, insulin and metabolic changes in response to acute myocardial infarction.
1972
[Evaluation of bones using quantitative ultrasonography].
1996
Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials
2007
[So-called "renal" idiopathic hypercalciuria most often has a dietary origin].
1988
Intravenous Zoledronic Acid in Postmenopausal Women With Low Bone Mineral Density
2003
Oral versus intravenous AHPrBP (APD) in the treatment of hypercalcemia of malignancy
1986
Calcitonin and reflex sympathetic dystrophy syndrome
1986
Long-term Results on Quality of Life of Surgical Treatment of Obesity with Vertical Banded Gastroplasty
1995
A single-day treatment of tumor-induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonate
1986
Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): Respective role of kidney and bone
1990
[The treatment of established osteoporosis].
1995
Osteoporosis in heart transplant recipients: a longitudinal study.
1994
Influence of the Calcium Content of the Diet on the Incidence of Mild Hyperoxaluria in Idiopathic Renal Stone Formers
1985
Paget's disease of bone treated in five days with AHPrBP (APD) per Os
1987
Short and long term results of a progressive reintroduction of carbohydrates (PRCH) after a protein-sparing modified fast (PSMF).
1989
Treatment of Hirsutism, Acne and Alopecia with Cyproterone Acetate
1980